Dr. John Cush RheumNow
3 years 3 months ago
Review of the etiology of Polyserositis (14 pts, 23 articles): most common - neoplasia (26.3%; Lung Lymphoma; ovarian; pancreatic), autoimmune (16.7% - SLE, AOSD) & infections (12.3%; coxackie, CMV, mTB). https://t.co/Bubd99ETgu https://t.co/VbiPB0y7pv
Dr. John Cush RheumNow
3 years 3 months ago
Disappointing Secondary Use of Newer Therapies in Psoriatic Arthritis
Analysis of patient data from five Nordic registries shows that the uptake of newer b/tsDMARDs in PsA was mainly in biologic-experienced patients.
https://t.co/SP9ZKGvM0J https://t.co/1tfSiWHYfl
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare form of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, affecting between 10 and 14 cases per million globally. This adult disorder has a mean age at diagnosis of nearly 50 years and affects both sexes equally, presenting with pulmonary symptoms (asthma), eosinophilia and granulomatous or vasculitic involvement of several organs. A multidisciplinary,
Fibromyalgia patients hoping to see a more effective and convenient formulation of cyclobenzaprine at their local pharmacies must wait for an ongoing phase III trial -- the product's third -- to finish, as the first two delivered mixed results.
A retrospecitve cohort comparision of juvenile (jSSc) and adult-onset (aSSc) systemic sclerosis (SSc) are both rare but present differently.
Dr. John Cush RheumNow
3 years 3 months ago
FDA approves a NGF inhbitor bedinvetmab (Librela) to treat osteoarthritis in Dogs!. Recently FDA approved NGF inhibitor cats w/ OA --- Yet 4 different NGF inhibitors failed in their development for human OA - are cats & dogs treated better than us? https://t.co/Tbca0PiEL2 https://t.co/Y7mViSa5J4
Dr. John Cush RheumNow
3 years 3 months ago
One in Ten is Bad!
This week on the Podcast Dr. Jack Cush reviews the news and journal articles, including the risks of dying, developing RA or autoimmune disease!
https://t.co/5SXPotfhs0 https://t.co/jXwsWoltsy
Dr. John Cush RheumNow
3 years 3 months ago
RheumThoughts: Giving Good Care in Diversity takes Time
Dr. Yvonne Sherrer and second-year fellow Dr. Corin Agoris discuss a case where extended time led to improved patient outcomes.
https://t.co/NRHBwHLqSi https://t.co/nj8eaGiU50
Dr. John Cush RheumNow
3 years 3 months ago
Watch: Meetings should be like Oktoberfest
https://t.co/pZGOYXINir https://t.co/RIXmpRztaL
Dr. John Cush RheumNow
3 years 3 months ago
Watch: Modern Management of PsA Faculty Panel Q&A ,
https://t.co/WIESJSL8WF https://t.co/0k7FyYkFtc
Dr. John Cush RheumNow
3 years 3 months ago
Chinese study of 4091 SLE pts, 3% (106) dx w/ osteonecrosis (AVN). AVN risk factors included:
- SLE onset age ≤ 30 (HR 1.6)
- Arthritis (HR 1.6)
- Organ damage (HR 2.6)
- RNP+ (HR 1.7)
- High steroid doses (HR 1.7) https://t.co/DnqhEIWztY https://t.co/aP0uh0oh1x
Dr. John Cush RheumNow
3 years 3 months ago
Proposed AOSD criteria: 80 AOSD vs 60 autoimmune pts: \Nneed 7 points = AOSD dx (sensitivity 92%, specificity 93%, AUC 93%):
- typical rash 3 pts
- fever ≥ 39°C 3 pts
- pharyngitis 2 pts
- arthritis 2 pts
- glycosylated ferritin≤ 20% 1 pt https://t.co/iLUryBVa7C https://t.co/HTWgAucBIm
Dr. John Cush RheumNow
3 years 3 months ago
2022 EULAR Recommendations on Screening and Prophylaxis for Opportunistic Infections
Opportunistic and chronic infections may be rare and are often difficult to diagnose, especially in patients with AIIRD, that may be immunocompromised.
https://t.co/eAN3X3kAHV https://t.co/qpFc7hlG7u

